 | Up a level |
Möller, Burkhard; Scholz, Godehard A; Amsler, Jennifer; Ciurea, Adrian; Micheroli, Raphael; Nissen, Michael J; Papagiannoulis, Eleftherios; Blapp, Christoph; Scherer, Almut; Yawalkar, Nikhil (2023). Biological disease-modifying anti-rheumatic drugs are equally effective in psoriatic arthritis patients with low and high joint counts. (In Press). Rheumatology Oxford University Press 10.1093/rheumatology/kead455
Amstad, Andrea; Papagiannoulis, Eleftherios; Scherer, Almut; Rubbert-Roth, Andrea; Finckh, Axel; Mueller, Ruediger; Dudler, Jean; Möller, Burkhard; Villiger, Peter M; Schulz, Martin M P; Kyburz, Diego (2022). Comparison of drug retention of TNF inhibitors, other biologics and JAK inhibitors in RA patients who discontinued JAK inhibitor therapy. Rheumatology, 62(1), pp. 89-97. Oxford University Press 10.1093/rheumatology/keac285
Ciurea, Adrian; Kissling, Seraphina; Bürki, Kristina; Baraliakos, Xenofon; de Hooge, Manouk; Hebeisen, Monika; Papagiannoulis, Eleftherios; Exer, Pascale; Bräm, René; Nissen, Michael J; Möller, Burkhard; Kyburz, Diego; Andor, Michael; Distler, Oliver; Scherer, Almut; Micheroli, Raphael (2022). Current differentiation between radiographic and non-radiographic axial spondyloarthritis is of limited benefit for prediction of important clinical outcomes: data from a large, prospective, observational cohort. RMD open, 8(1), e002067. BMJ Publishing Group 10.1136/rmdopen-2021-002067
Ciurea, Adrian; Papagiannoulis, Eleftherios; Bürki, Kristina; von Loga, Isabell; Micheroli, Raphael; Möller, Burkhard; Rubbert-Roth, Andrea; Andor, Michael; Bräm, René; Müller, Angela; Dan, Diana; Kyburz, Diego; Distler, Oliver; Scherer, Almut; Finckh, Axel (2021). Impact of the COVID-19 pandemic on the disease course of patients with inflammatory rheumatic diseases: results from the Swiss Clinical Quality Management cohort. Annals of the rheumatic diseases, 80(2), pp. 238-241. BMJ Publishing Group 10.1136/annrheumdis-2020-218705
